These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 22539085)
1. Combining synthetic carbohydrate vaccines with cancer cell glycoengineering for effective cancer immunotherapy. Qiu L; Gong X; Wang Q; Li J; Hu H; Wu Q; Zhang J; Guo Z Cancer Immunol Immunother; 2012 Nov; 61(11):2045-54. PubMed ID: 22539085 [TBL] [Abstract][Full Text] [Related]
2. A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells. Qiu L; Li J; Yu S; Wang Q; Li Y; Hu Z; Wu Q; Guo Z; Zhang J Oncotarget; 2015 Mar; 6(7):5195-203. PubMed ID: 25760071 [TBL] [Abstract][Full Text] [Related]
3. Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine. Chefalo P; Pan Y; Nagy N; Guo Z; Harding CV Biochemistry; 2006 Mar; 45(11):3733-9. PubMed ID: 16533056 [TBL] [Abstract][Full Text] [Related]
4. Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell. Wang Q; Zhang J; Guo Z Bioorg Med Chem; 2007 Dec; 15(24):7561-7. PubMed ID: 17892942 [TBL] [Abstract][Full Text] [Related]
5. Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse. Wang Q; Zhou Z; Tang S; Guo Z ACS Chem Biol; 2012 Jan; 7(1):235-40. PubMed ID: 22013921 [TBL] [Abstract][Full Text] [Related]
6. Recent development in carbohydrate-based cancer vaccines. Guo Z; Wang Q Curr Opin Chem Biol; 2009 Dec; 13(5-6):608-17. PubMed ID: 19766052 [TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines: an update with special focus on ganglioside antigens. Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591 [TBL] [Abstract][Full Text] [Related]
8. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model. Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884 [TBL] [Abstract][Full Text] [Related]
9. Improvement of the immune efficacy of carbohydrate vaccines by chemical modification on the GM3 antigen. Zheng XJ; Yang F; Zheng M; Huo CX; Zhang Y; Ye XS Org Biomol Chem; 2015 Jun; 13(22):6399-406. PubMed ID: 25982227 [TBL] [Abstract][Full Text] [Related]
10. Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies. Zhang J; Terreni M; Liu F; Sollogoub M; Zhang Y Biomed Pharmacother; 2024 Jul; 176():116824. PubMed ID: 38820973 [TBL] [Abstract][Full Text] [Related]
11. Enhanced interferon-gamma secretion and antitumor activity of T-lymphocytes activated by dendritic cells loaded with glycoengineered myeloma antigens. Xiong H; Wu QY; Hu HG; Liu B; Guo ZW; Sze DM; Hou J Chin Med J (Engl); 2007 Oct; 120(19):1678-84. PubMed ID: 17935669 [TBL] [Abstract][Full Text] [Related]
12. Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice. Stergiou N; Glaffig M; Jonuleit H; Schmitt E; Kunz H ChemMedChem; 2017 Sep; 12(17):1424-1428. PubMed ID: 28675699 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine Candidates. Yu S; Wang Q; Zhang J; Wu Q; Guo Z Medchemcomm; 2011 Jan; 2(6):524-530. PubMed ID: 21927709 [TBL] [Abstract][Full Text] [Related]
14. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Hakomori S Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen. Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644 [TBL] [Abstract][Full Text] [Related]
16. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti cancer vaccine for human use. Vichier-Guerre S; Lo-Man R; BenMohamed L; Dériaud E; Kovats S; Leclerc C; Bay S J Pept Res; 2003 Sep; 62(3):117-24. PubMed ID: 12895273 [TBL] [Abstract][Full Text] [Related]
17. Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines. Feng D; Shaikh AS; Wang F ACS Chem Biol; 2016 Apr; 11(4):850-63. PubMed ID: 26895482 [TBL] [Abstract][Full Text] [Related]
18. Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine. Yin Z; Chowdhury S; McKay C; Baniel C; Wright WS; Bentley P; Kaczanowska K; Gildersleeve JC; Finn MG; BenMohamed L; Huang X ACS Chem Biol; 2015 Oct; 10(10):2364-72. PubMed ID: 26262839 [TBL] [Abstract][Full Text] [Related]
19. Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy. Labrada M; Clavell M; Bebelagua Y; León Jd; Alonso DF; Gabri MR; Veloso RC; Vérez V; Fernández LE Expert Opin Biol Ther; 2010 Feb; 10(2):153-62. PubMed ID: 20088712 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines. Pan Y; Chefalo P; Nagy N; Harding C; Guo Z J Med Chem; 2005 Feb; 48(3):875-83. PubMed ID: 15689172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]